Transcriptomic analysis of pathways regulated by toll-like receptor 4 in a murine model of chronic pulmonary inflammation and carcinogenesis

23Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Therapeutic strategies exist for human pulmonary neoplasia, however due to the heterogeneity of the disease, most are not very effective. The innate immunity gene, toll-like receptor 4 (TLR4), protects against chronic pulmonary inflammation and tumorigenesis in mice, but the mechanism is unclear. This study was designed to identify TLR4-mediated gene expression pathways that may be used as prognostic indicators of susceptibility to lung tumorigenesis in mice and provide insight into the mechanism. Methods: Whole lung mRNA was isolated from C.C3H-Tlr4Lps-d(BALBLps-d; Tlr4 mutant) and BALB/c (Tlr4 normal) mice following butylated hydroxytoluene (BHT)-treatment (four weekly ip. injections; 150-200 mg/kg/each; "promotion"). mRNA from micro-dissected tumors (adenomas) and adjacent uninvolved tissue from both strains were also compared 27 wks after a single carcinogen injection (3-methylcholanthrene (MCA), 10 μg/g; "control") or followed by BHT (6 weekly ip. injections; 125-200 mg/kg/each; "progression"). Bronchoalveolar lavage fluid was analyzed for inflammatory cell content and total protein determination, a marker of lung hyperpermeability; inflammation was also assessed using immunohistochemical staining for macrophages (F4/80) and lymphocytes (CD3) in mice bearing tumors (progression). Results: During promotion, the majority of genes identified in the BALBLps-dcompared to BALB/c mice (P < 0.05) were involved in epithelial growth factor receptor (EGFR) signaling (e.g. epiregulin (Ereg)), secreted phosphoprotein 1(Spp1)), which can lead to cell growth and eventual tumor development. Inflammation was significantly higher in BALBLps-dcompared to BALB/c mice during progression, similar to the observed response during tumor promotion in these strains. Increases in genes involved in signaling through the EGFR pathway (e.g. Ereg, Spp1) were also observed during progression in addition to continued inflammation, chemotactic, and immune response gene expression in the BALBLps-dversus BALB/c mice (P < 0.05), which appears to provide more favorable conditions for cell growth and tumor development. In support of these findings, the BALB/c mice also had significantly reduced expression of many immune response and inflammatory genes in both the tumors and uninvolved tissue. Conclusion: This transcriptomic study determined the protective effect of TLR4 in lung carcinogenesis inhibition of multiple pathways including EGFR (e.g. Ereg), inflammatory response genes (e.g. Cxcl5), chemotaxis (e.g. Ccr1) and other cell proliferation genes (e.g. Arg1, Pthlh). Future studies will determine the utility of these pathways as indicators of immune system deficiencies and tumorigenesis. © 2009 Bauer et al; licensee BioMed Central Ltd.

References Powered by Scopus

EGFR mutations in lung, cancer: Correlation with clinical response to gefitinib therapy

8911Citations
N/AReaders
Get full text

Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene

6764Citations
N/AReaders
Get full text

Identification of bronchioalveolar stem cells in normal lung and lung cancer

1952Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: Its expression and effects in the ten most common cancers

112Citations
N/AReaders
Get full text

Targeted deletion of Nrf2 impairs lung development and oxidant injury in neonatal mice

87Citations
N/AReaders
Get full text

Targeted deletion of Nrf2 reduces urethane-induced lung tumor development in mice

84Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bauer, A. K., Fostel, J., Degraff, L. M., Rondini, E. A., Walker, C., Grissom, S. F., … Kleeberger, S. R. (2009). Transcriptomic analysis of pathways regulated by toll-like receptor 4 in a murine model of chronic pulmonary inflammation and carcinogenesis. Molecular Cancer, 8. https://doi.org/10.1186/1476-4598-8-107

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 15

63%

Professor / Associate Prof. 5

21%

Researcher 4

17%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 10

40%

Biochemistry, Genetics and Molecular Bi... 8

32%

Medicine and Dentistry 5

20%

Chemistry 2

8%

Save time finding and organizing research with Mendeley

Sign up for free